Risk of hematologic malignancies following herpes zoster after COVID-19: a global cohort study
These findings suggest that HZ following COVID-19 may serve as a clinical indicator of immune vulnerability and heightened susceptibility to hematologic and infectious disorders. Long-term monitoring may be warranted in high-risk populations.
Authors
- Joshua Wang (ORCID: https://orcid.org/0000-0002-9458-5665)
- Chien‐Lin Lu (ORCID: https://orcid.org/0000-0003-1435-6123)
- Chung‐Chi Yang (ORCID: https://orcid.org/0009-0000-8271-2885)
- Ching‐Liang Ho (ORCID: https://orcid.org/0000-0002-8378-1687)
- Kuo‐Cheng Lu (ORCID: https://orcid.org/0000-0002-7062-8560)
- Yanjun Wu (ORCID: https://orcid.org/0009-0007-3861-5712)
Institutions
- Fu Jen Catholic University (TW)
- Queensland University of Technology (AU)
- National Tsing Hua University (TW)
- Taipei Tzu Chi Hospital (TW)
- Taoyuan Armed Forces General Hospital (TW)
- National Defense Medical Center (TW)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-09-22
- DOI
- https://doi.org/10.3389/fmed.2025.1651614
- Citations
- 1
- Primary Topic
- Herpesvirus Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.35